WHO Identifies Potential Ebola Vaccines for Clinical Trials Amid Outbreak

The WHO said it is working closely with Congo and Uganda ‘to facilitate the implementation of research evaluation’ of the products.

Health workers conduct temperature screenings and health checks on travelers at a checkpoint in Goma, Congo, on May 24, 2026. Daniel Buuma/Getty Images

The World Health Organization (WHO) said on May 28 that experts have identified vaccine candidates and treatments for the Bundibugyo strain of Ebola that could be prioritized for clinical trials.

In a statement, the WHO said it has convened experts and advisory groups to assess potential vaccines and treatments for the Bundibugyo virus in response to the outbreak in Congo.